Vargo C - Search Results

1

The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer.

Johnson KCC, Goldstein D, Tharakan J, Quiroga D, Kassem M, Grimm M, Miah A, Vargo C, Berger M, Sudheendra P, Pariser A, Gatti-Mays ME, Williams N, Stover D, Sardesai S, Wesolowski R, Ramaswamy B, Tozbikian G, Schnell PM, Cherian MA. Johnson KCC, et al. Among authors: vargo c. Oncol Ther. 2023 Sep;11(3):361-374. doi: 10.1007/s40487-023-00235-6. Epub 2023 Jun 24. Oncol Ther. 2023. PMID: 37354381 Free PMC article.

2

Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction.

Berger MJ, Vargo C, Vincent M, Shaver K, Phillips G, Layman R, Macrae E, Mrozek E, Ramaswamy B, Wesolowski R, Shapiro CL, Lustberg MB. Berger MJ, et al. Among authors: vargo c. Support Care Cancer. 2015 Jul;23(7):2019-24. doi: 10.1007/s00520-014-2556-x. Epub 2014 Dec 18. Support Care Cancer. 2015. PMID: 25519756 Free PMC article.

3

Occurrence and characterization of everolimus adverse events during first and subsequent cycles in the treatment of metastatic breast cancer.

Vargo CA, Berger MJ, Phillips G, Mrozek E. Vargo CA, et al. Support Care Cancer. 2016 Jul;24(7):2913-8. doi: 10.1007/s00520-016-3105-6. Epub 2016 Feb 4. Support Care Cancer. 2016. PMID: 26847349

4

T-DM1 Activity in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancers That Received Prior Therapy With Trastuzumab and Pertuzumab.

Dzimitrowicz H, Berger M, Vargo C, Hood A, Abdelghany O, Raghavendra AS, Tripathy D, Valero V, Hatzis C, Pusztai L, Murthy R. Dzimitrowicz H, et al. Among authors: vargo c. J Clin Oncol. 2016 Oct 10;34(29):3511-3517. doi: 10.1200/JCO.2016.67.3624. J Clin Oncol. 2016. PMID: 27298406 Free PMC article.

5

Time to treatment failure of palbociclib and letrozole as second-line therapy or beyond in hormone receptor-positive advanced breast cancer.

Schickli MA, Berger MJ, Lustberg M, Palettas M, Vargo CA. Schickli MA, et al. J Oncol Pharm Pract. 2019 Sep;25(6):1374-1380. doi: 10.1177/1078155218794847. Epub 2018 Aug 22. J Oncol Pharm Pract. 2019. PMID: 30134767

6

Pathological complete response rates with pertuzumab-based neoadjuvant chemotherapy in breast cancer: A single-center experience.

Matthews CM, Nymberg K, Berger M, Vargo CA, Dempsey J, Li J, Ramaswamy B, Reinbolt R, Sardesai S, Wesolowski R, Williams N, Lustberg M. Matthews CM, et al. J Oncol Pharm Pract. 2020 Apr;26(3):572-579. doi: 10.1177/1078155219857800. Epub 2019 Jun 29. J Oncol Pharm Pract. 2020. PMID: 31256745

7

Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast Cancer.

Wilkie J, Schickli MA, Berger MJ, Lustberg M, Reinbolt R, Noonan A, Ramaswamy B, Sardesai S, VanDeusen J, Wesolowski R, Williams N, Stover DG, Li J, Vargo CA. Wilkie J, et al. Clin Breast Cancer. 2020 Feb;20(1):33-40. doi: 10.1016/j.clbc.2019.06.010. Epub 2019 Jul 17. Clin Breast Cancer. 2020. PMID: 31451366

8

Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience.

Suresh A, Ganju A, Morgan E, Palettas M, Stephens JA, Liu J, Berger M, Vargo C, Noonan A, Reinbolt R, Cherian M, VanDeusen J, Sardesai S, Wesolowski R, Stover DG, Lustberg M, Ramaswamy B, Williams N. Suresh A, et al. Among authors: vargo c. Invest New Drugs. 2020 Oct;38(5):1605-1611. doi: 10.1007/s10637-020-00891-9. Epub 2020 Jan 14. Invest New Drugs. 2020. PMID: 31938949

9

Comparison of subsequent infusion hypersensitivity reactions to paclitaxel using two different infusion strategies.

Nymberg K, Folan S, Berger M, Li J, Zanath K, VanDeusen J, Vargo C. Nymberg K, et al. Among authors: vargo c. Support Care Cancer. 2021 Aug;29(8):4423-4429. doi: 10.1007/s00520-021-05991-7. Epub 2021 Jan 14. Support Care Cancer. 2021. PMID: 33447864

10

Impact of Dose Intensity on Pathologic Complete Response Rate in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab and Pertuzumab (TCHP).

Le D, Vargo C, Collins S, Williams N, Palettas M, Berger M. Le D, et al. Among authors: vargo c. Target Oncol. 2022 Mar;17(2):167-175. doi: 10.1007/s11523-022-00874-1. Epub 2022 Mar 24. Target Oncol. 2022. PMID: 35325355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page